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REPLY
We thank Auer et al. for their comments on our paper (1).
Auer et al. would like to add atrial fibrillation (AF) after
cardiac surgery to the list of cardiovascular disorders that are
exacerbated by low serum potassium concentrations. Atrial
fibrillation is a common and costly complication after
cardiac surgery (2). It is significantly more common when
serum potassium falls below 3.5 mmol/l, and avoidance of
hypokalemia may reduce its incidence (3,4).
The stress of cardiothoracic surgery increases sympathetic
tone, and this may predispose one to the development of
AF. Interestingly, experimental evidence suggests that sym-
pathetic activity reduces the arrhythmic threshold of hy-
pokalemic dogs (5). This is unsurprising, given the data that
link catecholamines with hypokalemia and the favorable
effects of beta-blockade on the renin-angiotensin-
aldosterone system (6,7).
Therefore, we agree that avoidance of perioperative hy-
pokalemia in patients undergoing cardiothoracic surgery is
likely to reduce the incidence of AF in this setting and avoid
unnecessary morbidity and costs. A randomized controlled
trial of targeted potassium repletion versus standard care is
thus warranted.
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Aspirin “Allergy” and Resistance
In a recent article, Gum et al.(1) discussed aspirin resistance,
and Eikelboom et al. (2) wrote an editorial comment
regarding this topic. We have seen several patients who
reported that they seemed to have “allergic” reactions to
aspirin. These “allergic” reactions consisted primarily of
asthma-type attacks. Careful study revealed that these
patients are not “allergic” to aspirin in the classical way;
inhibition of cyclo-oxygenases by 325 mg of aspirin shifts
the arachidonic acid cascade to the lipo-oxygenase branch
(Fig. 1). This results in the production of more leukotreine
C4, D4, and E4, which together are the “slow-reacting
substance of anaphylaxis” and powerful bronchoconstrictors.
These patients then refuse to take aspirin and claim that
they are “resistant” to and have “allergies” to aspirin.
On the other hand, when patients are given only 81 mg
of aspirin, cyclo-oxygenase production recovers rapidly,
including prostaglandin i2 synthesis, which is platelet-
aggregation inhibitory and a vasodilator. Inhibition of the
platelet-aggregation inducer thromboxane A2 appears to
persist for several hours. It is generally accepted that
low-dose aspirin (81 mg one time daily) should be recom-
939JACC Vol. 44, No. 4, 2004 Letters to the Editor
August 18, 2004:936–40
mended as a preventive agent for cardiovascular episode in
patients who are not resistant to aspirin by the criteria
discussed by Gum et al. (1) and Eikelboom et al. (2). A
simple method used by our group to establish aspirin
resistance (3) is based on the determination of aggregated
platelets in the circulation and its resolution by one week of
aspirin therapy. This simple method can even be used as a
bedside procedure. It may be a screening method used
before introducing the spectrum of tests discussed by Eikel-
boom et al. (2). It is our impression that clopidogrel (75 mg
one time daily) alone or in combination with aspirin (81 mg
one time daily) is effective in possibly resistant patients.
Data are being collected for eventual statistical evaluation.
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Figure 1. The arachidonic acid cascade and its lipo-oxygenase branch,
determinants of aspirin side effects.
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